Detection of coding microsatellite frameshift mutations in DNA mismatch repair‐deficient mouse intestinal tumors

Different DNA mismatch repair (MMR)‐deficient mouse strains have been developed as models for the inherited cancer predisposing Lynch syndrome. It is completely unresolved, whether coding mononucleotide repeat (cMNR) gene mutations in these mice can contribute to intestinal tumorigenesis and whether MMR‐deficient mice are a suitable molecular model of human microsatellite instability (MSI)‐associated intestinal tumorigenesis. A proof‐of‐principle study was performed to identify mouse cMNR‐harboring genes affected by insertion/deletion mutations in MSI murine intestinal tumors. Bioinformatic algorithms were developed to establish a database of mouse cMNR‐harboring genes. A panel of five mouse noncoding mononucleotide markers was used for MSI classification of intestinal matched normal/tumor tissues from MMR‐deficient (Mlh1−/−, Msh2−/−, Msh2LoxP/LoxP) mice. cMNR frameshift mutations of candidate genes were determined by DNA fragment analysis. Murine MSI intestinal tumors but not normal tissues from MMR‐deficient mice showed cMNR frameshift mutations in six candidate genes (Elavl3, Tmem107, Glis2, Sdccag1, Senp6, Rfc3). cMNRs of mouse Rfc3 and Elavl3 are conserved in type and length in their human orthologs that are known to be mutated in human MSI colorectal, endometrial and gastric cancer. We provide evidence for the utility of a mononucleotide marker panel for detection of MSI in murine tumors, the existence of cMNR instability in MSI murine tumors, the utility of mouse subspecies DNA for identification of polymorphic repeats, and repeat conservation among some orthologous human/mouse genes, two of them showing instability in human and mouse MSI intestinal tumors. MMR‐deficient mice hence are a useful molecular model system for analyzing MSI intestinal carcinogenesis. © 2014 Wiley Periodicals, Inc.

[1]  R. Kucherlapati,et al.  The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. , 2000, Cancer research.

[2]  B. Vogelstein,et al.  Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. , 2003, Cancer research.

[3]  John Calvin Reed,et al.  Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Kucherlapati,et al.  Reduced Isotype Switching in Splenic B Cells from Mice Deficient in Mismatch Repair Enzymes , 1999, The Journal of experimental medicine.

[5]  M. Dasso,et al.  The fate of metaphase kinetochores is weighed in the balance of SUMOylation during S phase , 2010, Cell cycle.

[6]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[7]  N. Yoo,et al.  Mutational and expressional analysis of RFC3, a clamp loader in DNA replication, in gastric and colorectal cancers. , 2010, Human pathology.

[8]  T. Prolla,et al.  Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over , 1996, Nature Genetics.

[9]  T. Kunkel,et al.  Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. , 2003, Genes & development.

[10]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[11]  Deborah A Hursh,et al.  Drosophila caliban, a nuclear export mediator, can function as a tumor suppressor in human lung cancer cells , 2005, Oncogene.

[12]  P. Pandolfi,et al.  Haplo‐insufficiency: a driving force in cancer , 2011, The Journal of pathology.

[13]  Asad Umar,et al.  Meiotic Pachytene Arrest in MLH1-Deficient Mice , 1996, Cell.

[14]  P. Modrich.  Mechanisms in Eukaryotic Mismatch Repair* , 2006, Journal of Biological Chemistry.

[15]  L. Myeroff,et al.  Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells , 2008, Genes, chromosomes & cancer.

[16]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[17]  P. Glazer,et al.  Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts. , 2000, Carcinogenesis.

[18]  M. Radman,et al.  Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer , 1995, Cell.

[19]  R. Kucherlapati,et al.  Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. , 1999, Cancer research.

[20]  L. Edelmann,et al.  Loss of DNA mismatch repair function and cancer predisposition in the mouse: Animal models for human hereditary nonpolyposis colorectal cancer , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[21]  R. Hay,et al.  The SUMO protease SENP6 is a direct regulator of PML nuclear bodies , 2011, Molecular biology of the cell.

[22]  R. Kucherlapati,et al.  An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis , 2004, Cancer Research.

[23]  A. Magliocco,et al.  MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. , 2000, Blood.

[24]  G. Deng,et al.  Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. , 1999, Cancer research.

[25]  Yao-Tseng Chen,et al.  Characterization of human colon cancer antigens recognized by autologous antibodies , 1998, International journal of cancer.

[26]  R. Kucherlapati,et al.  A panel of repeat markers for detection of microsatellite instability in murine tumors , 2003, Molecular carcinogenesis.

[27]  A. Fischer,et al.  Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination , 2008, The Journal of experimental medicine.

[28]  Yan P. Yuan,et al.  Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes , 2003, Oncogene.

[29]  R. Halberg,et al.  Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors , 2005, Molecular carcinogenesis.

[30]  R. Kucherlapati,et al.  Mutation in the Mismatch Repair Gene Msh6 Causes Cancer Susceptibility , 1997, Cell.

[31]  Darryl Shibata,et al.  Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DMA mismatch repair , 1998, Nature Genetics.

[32]  T. Prolla,et al.  Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Yan P. Yuan,et al.  SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology , 2009, Nucleic Acids Res..

[34]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[35]  A. Tsotinis,et al.  Up‐regulation of a novel mRNA (NY‐CO‐1) involved in the methyl 4‐methoxy‐3‐(3‐methyl‐2‐butenoyl) benzoate (VT1)‐induced proliferation arrest of a non‐small‐cell lung carcinoma cell line (NSCLC‐N6) , 2001, International Journal of Cancer.

[36]  R. Kucherlapati,et al.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents. , 2010, Gastroenterology.

[37]  Yan P. Yuan,et al.  Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair‐deficient cancer cells , 2001, International journal of cancer.

[38]  H. Griesser,et al.  MSH2 deficient mice are viable and susceptible to lymphoid tumours , 1995, Nature Genetics.

[39]  Matej Horvat,et al.  Microsatellite instability in colorectal cancer , 2011, Radiology and oncology.

[40]  H. S. Kang,et al.  Gli-similar proteins: their mechanisms of action, physiological functions, and roles in disease. , 2012, Vitamins and hormones.

[41]  W. Lam,et al.  Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma , 2012, Clinical Cancer Research.

[42]  P. Glazer,et al.  Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Friedman,et al.  Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Mimi Y. Kim,et al.  Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility. , 2004, Cancer cell.

[45]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.